ACH
Accendra Health, Inc.
NYSE · USHealthcareMedical - Distribution
$3.32-4.32%
Price as of Jul 20, 2026
ACH growth
Accendra Health, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- -59.3%
- EBITDA
- +619.6%
- EBIT
- +187.8%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
- Revenue
- -3.3%
- EBITDA
- -53.3%
- EPS
- +107.5%
Three-year CAGR
- Revenue
- -34.8%
- EBITDA
- -15.8%
- EBIT
- +15.8%
- Net income
- —
- EPS
- —
- Free cash flow
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.